Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
ALX Oncology Holdings Inc.:
We consent to the use of our report dated June 12, 2020, included herein, with respect to the balance sheet of ALX Oncology Holdings Inc. as of April 1, 2020 (inception), and the related notes, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Francisco, California
June 26, 2020
